Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 218-002-7 | CAS number: 2035-93-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted in accordance with standard test guidelines (OECD TG 473) and is GLP compliant.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- other: human lymphocytes
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/ß-naphthoflavone induced rat liver S9-mix
- Test concentrations with justification for top dose:
- Experiment I - 11.6 to 1780 ug/mL (10 dose levels)
Experiment II - without S9 mix 3.8 to 581.2 ug/mL (10 dose levels); with S9 mix 62.0 to 1780 ug/mL (7 dose levels) - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO (purity 99.5%)
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
In medium; in agar (plate incorporation); preincubation; in suspension; as impregnation on paper disk
DURATION
- Preincubation period: 50-80 hours
- Exposure duration: Experiment I, 4 or 22 hours without S9 ; 22 hours with S9. Experiment II, 46 hours without S9 ; 4 hours with S9 mix
- Expression time (cells in growth medium): 22 or 46 hours
- Selection time (if incubation with a selection agent):
- Fixation time (start of exposure up to fixation or harvest of cells): 19 or 43 hours
SPINDLE INHIBITOR (cytogenetic assays): colchicine
STAIN (for cytogenetic assays): Giesma staining or Fluorescent plus Giesma staining for each duplicate
NUMBER OF REPLICATIONS: Two
NUMBER OF CELLS EVALUATED:at least 1000 per culture
DETERMINATION OF CYTOTOXICITY
- Method: reduced mitotic index
OTHER EXAMINATIONS:
- Analysis of metaphase cells for breaks, fragments ,deletions, exchanges and chromosomal disintegrations - Evaluation criteria:
- Test item is classed as mutagenic if the number of indiced aberrations is outside the historical control range of 0.0 -0.4% AND a concentration related or significant increase of the number of structural abnormalities is observed.
Test item is anuegenic if the number of induced aberrations (polyploidy and endoreduplication) is outside the range of historical contol data (0.0 to 0.8% polyploidal cells). - Statistics:
- Fischers exact test (p<0.05)
- Species / strain:
- lymphocytes: human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 189.8 ug/mL and above
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no increase in pH value was noted : control =7.0, high dose of 1780 ug/mL =7.1
- Effects of osmolality: no increase in osmolality was noted : control =395mOsm; high dose of 1780 ug/mL =394 mOsm
- Precipitation: evident at doses of 581.2 ug/mL and above
- Other confounding effects:
RANGE-FINDING/SCREENING STUDIES: Yes at 10 dose levels to determine cytoxicity.,
COMPARISON WITH HISTORICAL CONTROL DATA: used to determine mutagenicity/non mutagenicty and polyploidy. - Remarks on result:
- other: other:
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative
Under the test conditions, 4-methyl-4-phenylpentan-2-ol did not induce structural chromosomal aberrations in human lymphocytes in vitro in the presence and absence of metabolic activation. - Executive summary:
The test item, 4-Methyl-4-phenylpentan-2-ol, was assessed for its potential to induce chromosomal aberrations in human lymphocytes in the presence and absence of metabolic activation by S9 mix. In a study conducted in accordance with OECD test guideline 473, two experiments were performed . In Experiment I the exposure periods were 4 hours with and without S9 mix and 22 hours without S9 mix. Chromosomes were prepared 22 hours after start of exposure. In Experiment II - exposure periods were 4 hours with S9 mix and 46 hours without S9 mix. Chromosomes were prepared 46 hours after start of exposure. Doses were as follows - Experiment I - 11.6 to 1780 ug/mL (10 dose levels) ; Experiment II - without S9 mix 3.8 to 581.2 ug/mL (10 dose levels); with S9 mix 62.0 to 1780 ug/mL (7 dose levels). In each experiment two parallel cultures were analysed. 100 metaphase plates per culture were scored for structural chromosomal aberrations.- at least 1000 cells per culture were counted for determination of mitotic index.
In both Experiment I and Experiment II in the absence and presence of S9 mix, no biologically relevant increase in the number of cells carrying structural chromosome aberrations was observed. The aberration rates of cells after treatment (0 to 4.0% aberrant cells excluding gaps) were within the range of the laboratory's control data. However in experiment II after continuous treatment without S9 mix the aberration rate of 4.0% achieved statistical significance but was not considered to be biologically relevant as this value fell within the laboratory's historical control data.
Under the test conditions, 4-methyl-4-phenylpentan-2-ol did not induce structural chromosomal aberrations in human lymphocytes in vitro in the presence and absence of metabolic activation.
Reference
In Experiment I and Experiment II in the absence and presence of S9 mix, no biologically relevant increase in the number of cells carrying structural chromosome aberrations was observed.
The aberration rates of cells after treatment (0 to 4.0% aberrant cells excluding gaps) were within the range of the laboratory's control data. However in experiment II after continuous treatment without S9 mix the aberration rate of 4.0% achieved statistical significance but was not considered to be biologically significant as this value fell within the laboratory's historical control data.
In both experiments, there was no biologically relevant increase in the rate of polyploid metaphases (0 to 0.4%) as compared to controls (0 to 0.2%).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Justification for selection of genetic toxicity endpoint
Three key in vitro genetic toxicity studies have been conducted with 4-methyl-4-phenylpentan-2-ol. The two in vitro mutagenicty studies, one in bacterial cells and one in mammalian cells, were both negative and the cytogenicity study in human lymphocytes was also negative. It is the study in human cells which has been selected as the key study for this endpoint summary.
Justification for classification or non-classification
Negative results were produced in an in vitro cytogenicity study in mammalian cells, in a gene mutation study in mammalian cells and also in a gene mutation study in bacterial cells. Therefore, no classification is required for this endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.